Javascript must be enabled to continue!
mtDNA “Nomenclutter” and its Consequences on the Interpretation of Genetic Data
View through CrossRef
Abstract
Population-based studies of human mitochondrial genetic diversity often require the classification of mitochondrial DNA (mtDNA) haplotypes into more than 5400 described haplogroups, and further grouping those into hierarchically higher haplogroups. Such secondary haplogroup groupings (e.g., “macro-haplogroups”) vary across studies, as they depend on the sample quality, technical factors of haplogroup calling, the aims of the study, and the researchers’ understanding of the mtDNA haplogroup nomenclature. Retention of historical nomenclature coupled with a growing number of newly described mtDNA lineages results in increasingly complex and inconsistent nomenclature that does not reflect phylogeny well. This “clutter” leaves room for grouping errors and inconsistencies across scientific publications, especially when the haplogroup names are used as a proxy for secondary groupings, and represents a source for scientific misinterpretation.
Here we explore the effects of phylogenetically insensitive secondary mtDNA haplogroup groupings, and the lack of standardized secondary haplogroup groupings on downstream analyses and interpretation of genetic data. We demonstrate that frequency-based analyses produce inconsistent results when different secondary mtDNA groupings are applied, and thus allow for vastly different interpretations of the same genetic data. The lack of guidelines and recommendations on how to choose appropriate secondary haplogroup groupings presents an issue for the interpretation of results, as well as their comparison and reproducibility across studies.
To reduce biases originating from arbitrarily defined secondary nomenclature-based groupings, we suggest that future updates of mtDNA phylogenies aimed for the use in mtDNA haplogroup nomenclature should also provide well-defined and standardized sets of phylogenetically meaningful algorithm-based secondary haplogroup groupings such as “macro-haplogroups”, “meso-haplogroups”, and “micro-haplogroups”. Ideally, each of the secondary haplogroup grouping levels should be informative about different human population history events. Those phylogenetically informative levels of haplogroup groupings can be easily defined using
TreeCluster
, and then implemented into haplogroup callers such as
HaploGrep3
. This would foster reproducibility across studies, provide a grouping standard for population-based studies, and reduce errors associated with haplogroup nomenclatures in future studies.
Title: mtDNA “Nomenclutter” and its Consequences on the Interpretation of Genetic Data
Description:
Abstract
Population-based studies of human mitochondrial genetic diversity often require the classification of mitochondrial DNA (mtDNA) haplotypes into more than 5400 described haplogroups, and further grouping those into hierarchically higher haplogroups.
Such secondary haplogroup groupings (e.
g.
, “macro-haplogroups”) vary across studies, as they depend on the sample quality, technical factors of haplogroup calling, the aims of the study, and the researchers’ understanding of the mtDNA haplogroup nomenclature.
Retention of historical nomenclature coupled with a growing number of newly described mtDNA lineages results in increasingly complex and inconsistent nomenclature that does not reflect phylogeny well.
This “clutter” leaves room for grouping errors and inconsistencies across scientific publications, especially when the haplogroup names are used as a proxy for secondary groupings, and represents a source for scientific misinterpretation.
Here we explore the effects of phylogenetically insensitive secondary mtDNA haplogroup groupings, and the lack of standardized secondary haplogroup groupings on downstream analyses and interpretation of genetic data.
We demonstrate that frequency-based analyses produce inconsistent results when different secondary mtDNA groupings are applied, and thus allow for vastly different interpretations of the same genetic data.
The lack of guidelines and recommendations on how to choose appropriate secondary haplogroup groupings presents an issue for the interpretation of results, as well as their comparison and reproducibility across studies.
To reduce biases originating from arbitrarily defined secondary nomenclature-based groupings, we suggest that future updates of mtDNA phylogenies aimed for the use in mtDNA haplogroup nomenclature should also provide well-defined and standardized sets of phylogenetically meaningful algorithm-based secondary haplogroup groupings such as “macro-haplogroups”, “meso-haplogroups”, and “micro-haplogroups”.
Ideally, each of the secondary haplogroup grouping levels should be informative about different human population history events.
Those phylogenetically informative levels of haplogroup groupings can be easily defined using
TreeCluster
, and then implemented into haplogroup callers such as
HaploGrep3
.
This would foster reproducibility across studies, provide a grouping standard for population-based studies, and reduce errors associated with haplogroup nomenclatures in future studies.
Related Results
54 THE DEVELOPMENT AND CHARACTERIZATION OF MITOCHONDRIAL DNA
(MTDNA)-DEPLETED CAPRA HIRCUS FETAL FIBROBLASTS: CANDIDATE DONORS FOR SOMATIC
CELL NUCLEAR TRANSFER (SCNT)
54 THE DEVELOPMENT AND CHARACTERIZATION OF MITOCHONDRIAL DNA
(MTDNA)-DEPLETED CAPRA HIRCUS FETAL FIBROBLASTS: CANDIDATE DONORS FOR SOMATIC
CELL NUCLEAR TRANSFER (SCNT)
Mammalian mtDNA is approximately 16.6 kb in size. It has 37 genes, 13 of which encode protein subunits of the oxidative phosphorylation (OXPHOS) system, the major ATP-generating pa...
Generation of mtDNA Homoplasmic Cloned Lambs
Generation of mtDNA Homoplasmic Cloned Lambs
Abstract
Generally in mammals, individual animals contain only maternally inherited mitochondrial DNA (mtDNA), as paternal (sperm)-derived mi...
MitoDelta: identifying mitochondrial DNA deletions at cell-type resolution from single-cell RNA sequencing data
MitoDelta: identifying mitochondrial DNA deletions at cell-type resolution from single-cell RNA sequencing data
AbstractBackgroundDeletion variants in mitochondrial DNA (mtDNA) are associated with various diseases, such as mitochondrial disorders and neurodegenerative diseases. Traditionally...
Leukocyte telomere length and mitochondrial DNA copy number associate with endothelial function in aging-related cardiovascular disease
Leukocyte telomere length and mitochondrial DNA copy number associate with endothelial function in aging-related cardiovascular disease
BackgroundWe investigated the association between leukocyte telomere length, mitochondrial DNA copy number, and endothelial function in patients with aging-related cardiovascular d...
ASSA13-06-1 New Findings from Myocardial Mitochondria DNA Sequencing of Patients with Left Ventricular Non-Compaction Cardiomyopathy
ASSA13-06-1 New Findings from Myocardial Mitochondria DNA Sequencing of Patients with Left Ventricular Non-Compaction Cardiomyopathy
Background
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare congenital cardiomyopathy that is widely believed to be arrest of cardiac development d...
Mitochondrial genome-encoded long noncoding RNA and mitochondrial stability in diabetic retinopathy
Mitochondrial genome-encoded long noncoding RNA and mitochondrial stability in diabetic retinopathy
<p>Mitochondria experience genomic and functional instability in diabetes, and mitochondrial dysfunction has a critical role in the development of diabetic retinopathy. Diabe...
The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective
The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective
Abstract
The introduction of nuclear transfer (NT) and other technologies that involve embryo reconstruction require us to reinvestigate patterns of mitochondrial...
Abstract Fri056: Mitochondrial DNA (mtDNA) Serves as a Potential Mediator and Prognostic Indicator of Doxorubicin Induced Cardiotoxicity
Abstract Fri056: Mitochondrial DNA (mtDNA) Serves as a Potential Mediator and Prognostic Indicator of Doxorubicin Induced Cardiotoxicity
Background:
Cardiotoxicity and subsequent cardiac dysfunction are well-documented sequelae of anthracycline-based chemotherapy treatment. Previous studies have establis...

